Live Breaking News & Updates on துறை ஆஃப் இருதய மருந்து

Stay updated with breaking news from துறை ஆஃப் இருதய மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Millennials Flock to Telehealth, Online Research


Millennials Flock to Telehealth, Online Research
By Batya Swift Yasgur, MA
April 2, 2021 The internet is often the first place many of us go to find information, whether it’s about hotels, music, or furniture. And health guidance is no exception especially among millennials.
A new survey of 2,040 millennials (ages 23 to 39) in February by Harmony Healthcare IT found that 69% of respondents searched online for health and medical advice instead of going to the doctor, and a quarter of respondents trust Google to accurately diagnose their symptoms. Also, a strong majority (83%) are doing their own research, even after hearing advice from their doctor, and 42% trust their own research more than that of their doctor. ....

United States , Collin Czarnecki , Amir Lerman , Everyday Health , Department Of Cardiovascular Medicine , Harmony Healthcare , Chest Pain , Coronary Physiology Clinic , Cardiovascular Medicine , Mayo Clinic , Millennials Dont Want , Millennial Health , Covid 19 , Corona Virus , ஒன்றுபட்டது மாநிலங்களில் , கோலின் கிசார்னேக்கி , அமீர் லெர்மன் , தினமும் ஆரோக்கியம் , துறை ஆஃப் இருதய மருந்து , நல்லிணக்கம் சுகாதாரம் , மார்பு வலி , கரோனரி உடலியல் சிகிச்சையகம் , இருதய மருந்து , மயோ சிகிச்சையகம் , மில்லினியல்கள் டோன்ட் வேண்டும் , ஆயிரக்கணக்கான ஆரோக்கியம் ,

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A


Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A
Cardiol Therapeutics Inc. (
a clinical-stage biotechnology company
focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, today filed its audited Financial Statements and Management s Discussion and Analysis for the year ended December 31, 2020. Both are available under the Company s profile on SEDAR at www.sedar.com and on the Company s website at www.cardiolrx.com.
David Elsley, President and Chief Executive Officer of Cardiol, commented: 2020 was a very exciting year for Cardiol Therapeutics. We made extraordinary progress in our research and clinical development programs, while significantly strengthening our financial position. We are particularly excited about the progress made across our research and development programs supporting the development of CardiolRx, our pharmaceutically produced extra- ....

United States , Guilherme Oliveira , Carsten Tsch , Weldon Smith , David Elsley , Matthias Friedrich , Wilson Tang , Trevor Burns , Andrew Hamer , Peter Liu , Arvind Bhimaraj , Barry Trachtenberg , Heart Failure Research , Data Safety Monitoring Committee , Cardiol Therapeutics Inc , Shoppers Drug Mart Inc , Department Of Cardiovascular Medicine , University Of Pittsburgh , University Of Ottawa Heart Institute , Leslie Cooper Co , Mcgill University Health Centre , York Stock Exchange , Company Phase , Mayo Clinic Enterprise Department Of Cardiovascular Medicine , Steering Committee , American College Of Cardiology ,

Researchers develop mobile EKG device that can identify patients at risk of sudden cardiac death


Researchers develop mobile EKG device that can identify patients at risk of sudden cardiac death
Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research has yielded a breakthrough in determining the health of the electrical recharging system in a patient s heart.
The researchers determined that a smartphone-enabled mobile EKG device can rapidly and accurately determine a patient s QTc, thereby identifying patients at risk of sudden cardiac death from congenital long QT syndrome (LQTS) or drug-induced QT prolongation.
The heart beats by a complex system of electrical signals triggering regular and necessary contractions. Clinicians evaluate the heart s rate-corrected QT interval, or QTc, as a vital health barometer of the heart s electrical recharging system. A potentially dangerous prolonged QTc, which is equal to or longer th ....

David Albert , Paul Friedman , Windland Smith , Alivecor Kardiamobile , John Giudicessi , Michael Ackerman , Emily Henderson , Department Of Cardiovascular Medicine , Alivecor Inc , Drug Administration , Mayo Clinic , Windland Smith Rice Genetic Heart Rhythm , Cardiovascular Medicine , டேவிட் ஆல்பர்ட் , பால் ப்ரைட்மேன் , மைக்கேல் அக்கர்மன் , எமிலி ஹென்டர்சன் , துறை ஆஃப் இருதய மருந்து , மயோ சிகிச்சையகம் , இருதய மருந்து ,